EMV Capital

Investment thesis

Listed (part of NetScientific) deep tech and life sciences VC investing in early-stage, IP-rich companies with attractive intellectual property, using a capital-efficient model that blends balance-sheet investment with syndicated deals plus IP strategy and hands-on management. Acquired Cambridge deeptech investor Martlet Capital in 2024.

Sector focus